It is well-known that there are some situations in which physicians continue to resist the use of mobile health solutions, and a recent study published in JMIR at the beginning of May sought to identify some of the factors that play a key role in the adoption of a free oncology decision support app.
Oncology is a growing space in digital health. CE-approved ONCOassist, launched in 2012, gives...
In an open Nature Communications paper published today, researchers from the University of Michigan described a prototype wearable device that could continuously collect bloodborne cancer cells often used as a biomarker for treatment.
Currently, blood draws are required to identify and examine circulating tumor cells (CTCs), and are often limited by inconsistent CTC counts as well as the health...
Burning Rock Biotech, which was founded in 2014 and focuses on NGS (Next-Generation Sequencing) diagnostics solutions for precision medicine in oncology, today announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures (LAV), Sequoia Capital China and T&Brothers Capital. The...
Earlier this week Oncology Analytics, a technology company focused on helping organizations apply and manage benefits for cancer care, announced that it closed a $21 million Series B funding round. The new round was led by Oak HC/FT with participation from McKesson Ventures, Blue Cross Blue Shield Venture Partners and Sandbox Advantage.
The company said the new money will help it expand its...
Artificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, called Eureka Health Oncology, that uses EMR data to provide practical AI applications for real oncology use cases.
“Our team of healthcare professionals is using the deep clinical oncology dataset at...
Pharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement. Roche will pay an additional $1.9 billion over the millions it had already invested into the company in 2016, and as a result of the deal will control all shares of Flatiron Health.
“This is an important step in our personalized healthcare...
Two years after launching its smoking cessation app Quitter's Circle, pharmaceutical company Pfizer is seeing impressive continued engagement with the app. It's also applying the lessons learned from Quitter's Circle toward other mobile health pursuits — including a recently-launched app for people living with cancer.
"We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy...
Cedars-Sinai Medical Center is embarking on a small study to see if a Fitbit Charge HR can help oncologists assess whether their patients are active enough for chemotherapy.
“What we know is that individuals who are up and about tend to be more able to tolerate chemotherapy and have a greater potential for benefitting from it,” Dr. Arvind Shinde, a faculty physician in the departments of...
Voluntis's Diabeo app, not available in the United States
French medical app company Voluntis is partnering with Roche Pharma France, a subsidiary of Roche, to develop a mobile-based therapy for breast cancer.
Voluntis makes companion apps as medical devices. It has so far focused on the areas of diabetes, hemophilia, and coagulation. Voluntis actually worked with Roche Diagnostics in the past...
Innovation in digital health won’t come in a gradual, incremental way, but rather through dramatic re-imaginings of care. That was the theme that ran through the morning conversation in the digital health track at the 2015 BIO International Convention, a pharma and life sciences-focused conference held in Philadelphia this week.
“We’re in a disruptive time. We’re in a time of moonshots, when...
